title: 1-40 Beta-amyloid protein fragment modulates the expression of CD44 and CD71 on the astrocytoma cell line in the presence of IL1beta and TNFalpha.
abstract: The modulation of CD44, VCAM-1 and CD71 expression was analysed by flow cytometry in the 1321N1 astrocytoma cell line in the presence of interleukin-1beta (IL1beta), tumour necrosis factor-alpha (TNFalpha) and 1-40 or 25-35 beta-amyloid (Abeta) fragments. The percentage of 1321N1 astrocytoma cell line expressing these markers increased significantly after treatment with TNFalpha or IL1beta. The presence of Abeta 1-40 fragment, alone or in combination with IL1beta, induced an increase in the percentage of cells expressing CD44, but not VCAM-1. However, the concomitant presence of Abeta 1-40 fragment and of IL1beta or TNFalpha caused an increase in the percentage of CD71 positive cells. In contrast, the shorter Abeta 25-35 fragment was always inactive. These results indicates that Abeta 1-40 fragment, in association with cytokines, can activate this astrocyte-derived cell line and add further elements in favour of the hypothesis that beta-amyloid can act as immunological mediator.
authors.affiliation: Laboratory of Biology, ONLUS, IRCCS Milan, Italy.
authors.forename: Livianna
authors.initials: L
authors.lastname: Speciale
authors.forename: Stefania
authors.initials: S
authors.lastname: Ruzzante
authors.forename: Elena
authors.initials: E
authors.lastname: Calabrese
authors.forename: Marina
authors.initials: M
authors.lastname: Saresella
authors.forename: Donatella
authors.initials: D
authors.lastname: Taramelli
authors.forename: Claudio
authors.initials: C
authors.lastname: Mariani
authors.forename: Laura
authors.initials: L
authors.lastname: Bava
authors.forename: Renato
authors.initials: R
authors.lastname: Longhi
authors.forename: Pasquale
authors.initials: P
authors.lastname: Ferrante
mesh_terms: D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D015703:Antigens, CD / Q000378:metabolism*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000378:metabolism*; D001254:Astrocytoma / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D018960:Hyaluronan Receptors / Q000378:metabolism*; D007375:Interleukin-1 / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D011990:Receptors, Transferrin; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; C068126:CD71 antigen; D018960:Hyaluronan Receptors; D007375:Interleukin-1; D010446:Peptide Fragments; D011990:Receptors, Transferrin; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; C078592:amyloid beta-protein (1-40)